ACHV
Price
$5.75
Change
+$0.15 (+2.68%)
Updated
Jun 10 closing price
Capitalization
590.29M
56 days until earnings call
Intraday BUY SELL Signals
ARRY
Price
$6.83
Change
-$0.57 (-7.69%)
Updated
Jun 10 closing price
Capitalization
1.05B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs ARRY

Header iconACHV vs ARRY Comparison
Open Charts ACHV vs ARRYBanner chart's image
ACHV vs ARRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACHV vs. ARRY commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Buy and ARRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 11, 2026
Stock price -- (ACHV: $5.75 vs. ARRY: $6.84)
Brand notoriety: ACHV and ARRY are both not notable
ACHV represents the Biotechnology, while ARRY is part of the Alternative Power Generation industry
Current volume relative to the 65-day Moving Average: ACHV: 83% vs. ARRY: 131%
Market capitalization -- ACHV: $590.29M vs. ARRY: $1.05B
ACHV [@Biotechnology] is valued at $590.29M. ARRY’s [@Alternative Power Generation] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.59B to $0. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B. The average market capitalization across the [@Alternative Power Generation] industry is $2.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileARRY’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • ARRY’s FA Score: 1 green, 4 red.
According to our system of comparison, ARRY is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish while ARRY’s TA Score has 5 bullish TA indicator(s).

  • ACHV’s TA Score: 5 bullish, 4 bearish.
  • ARRY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ACHV and ARRY are a good buy in the short-term.

Price Growth

ACHV (@Biotechnology) experienced а +16.87% price change this week, while ARRY (@Alternative Power Generation) price change was -21.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.24%. For the same industry, the average monthly price growth was -7.47%, and the average quarterly price growth was -4.07%.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -9.36%. For the same industry, the average monthly price growth was -3.26%, and the average quarterly price growth was +9.14%.

Reported Earning Dates

ACHV is expected to report earnings on Aug 06, 2026.

ARRY is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-4.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Alternative Power Generation (-9.36% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($1.05B) has a higher market cap than ACHV($590M). ACHV YTD gains are higher at: 15.694 vs. ARRY (-25.868). ARRY has higher annual earnings (EBITDA): 29.6M vs. ACHV (-50.86M). ARRY has more cash in the bank: 201M vs. ACHV (29.3M). ACHV has less debt than ARRY: ACHV (15M) vs ARRY (763M). ARRY has higher revenues than ACHV: ARRY (1.21B) vs ACHV (0).
ACHVARRYACHV / ARRY
Capitalization590M1.05B56%
EBITDA-50.86M29.6M-172%
Gain YTD15.694-25.868-61%
P/E RatioN/A56.91-
Revenue01.21B-
Total Cash29.3M201M15%
Total Debt15M763M2%
FUNDAMENTALS RATINGS
ACHV vs ARRY: Fundamental Ratings
ACHV
ARRY
OUTLOOK RATING
1..100
8973
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4061
P/E GROWTH RATING
1..100
10030
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (81) in the Biotechnology industry is in the same range as ARRY (98). This means that ACHV’s stock grew similarly to ARRY’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that ACHV’s stock grew similarly to ARRY’s over the last 12 months.

ACHV's SMR Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that ACHV’s stock grew similarly to ARRY’s over the last 12 months.

ACHV's Price Growth Rating (40) in the Biotechnology industry is in the same range as ARRY (61). This means that ACHV’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (30) in the Biotechnology industry is significantly better than the same rating for ACHV (100). This means that ARRY’s stock grew significantly faster than ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVARRY
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signal:
Gain/Loss:
ARRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMDCX2.69N/A
N/A
Virtus Silvant Mid-Cap Growth C
TRSSX26.81N/A
N/A
T. Rowe Price Instl Small-Cap Stock
QRSVX52.31N/A
N/A
FPA Queens Road Small Cap Value Inv
MGFYX8.14N/A
N/A
MassMutual Global Svc
CWICX77.90-1.55
-1.95%
American Funds Capital World Gr&Inc 529C

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
+2.68%
ALT - ACHV
47%
Loosely correlated
-1.88%
RANI - ACHV
35%
Loosely correlated
-3.48%
DARE - ACHV
32%
Poorly correlated
+4.17%
RAIN - ACHV
31%
Poorly correlated
-3.83%
RNAC - ACHV
30%
Poorly correlated
+7.74%
More